{"name":"Onconic Therapeutics Inc.","slug":"onconic-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"JP-1366","genericName":"JP-1366","slug":"jp-1366","indication":"Other","status":"phase_2"},{"name":"JP-1366 and clopidogrel","genericName":"JP-1366 and clopidogrel","slug":"jp-1366-and-clopidogrel","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"JP-1366","genericName":"JP-1366","slug":"jp-1366","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"JP-1366 and clopidogrel","genericName":"JP-1366 and clopidogrel","slug":"jp-1366-and-clopidogrel","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1lSmtCTTRSLVQtMGkwdlVxbFVOQnpDbFF1dWxYVzg5V2c3Z2ZMMW15STA3OVFLbWFDT3lDVHJXc0paS2lNTFp2eWZBOFB6Z1lENFMxMHVNTzNBbnVrVm9oVF81R2xKTEJmS2dQbV9R0gFyQVVfeXFMTm1sUTJJcGhrZk9nTVpUZklhcWVtTms0TWJYTV9KMWF2Mlh5VFBTYVpMNEhpbDhrZ2Y4RmdWQjNOQlh3YU9Ia1NCd3N6QmtjcW1hTllKdTR3MV9aOS0tR3QzQnR3MXBmdlMtdVFwdC1SWld3?oc=5","date":"2026-04-01","type":"trial","source":"koreabiomed.com","summary":"Onconic advances Jaqbo lifecycle with phase 3 maintenance trial in GERD - koreabiomed.com","headline":"Onconic advances Jaqbo lifecycle with phase 3 maintenance trial in GERD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE52ZkJkRXYxNzlFV00yX1FKOU5kXzA4UHduRm9FMlJUSEE4bTFuTHR6a255Q1lVcW5YUlR5aHdTVmFGVXMzX1dqdEJibV9YU21TLVJ1UTlJR0h5bEYtNzhQODgyck44ZXNlMTRjaDNR0gFyQVVfeXFMTUd2c3ZxX1JrX0ZqM1BTMWJ3NlZxaDNmbE5PR1p0VThZUUY5SUtDT29mOVcxd3hCVThiNk9BUmZKX2FoQUMwRk5KTHVxYzVWdXRvRGlpR3FscmdMdWptYVpFblNrSnlUZF9TUUhHMC1aY1J3?oc=5","date":"2025-08-18","type":"trial","source":"koreabiomed.com","summary":"Onconic Therapeutics’ GERD drug Jaqbo heads to China after phase 3 success - koreabiomed.com","headline":"Onconic Therapeutics’ GERD drug Jaqbo heads to China after phase 3 success","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE80NkVZOEVIOWVVeTBFLWtGNEdvNm04Uko3UTZMX2J2MHE2QWJzVzkzMjY3aTZGQkZQUkp4eGlMMDN1UVdQU1g5dC1JYTZLX3l6SGsyUTVDOE1PaXl2OXNVcmUzOFBhN0hIWHBEVm530gFyQVVfeXFMTWZaSnF2dkhaQ2Vxbks2YWVienBvSmJ4Q0gtTlJfNHF6dDBtc3VGWVVXRXdTWUF6bHlNd2FOTFdjbnlEVlVHWjc4a240aXhMMjlkUGlWOTJsdVEtNDdoMXdtMlpVSTFIRy1EYXJqRnlvbjh3?oc=5","date":"2025-06-18","type":"pipeline","source":"koreabiomed.com","summary":"Onconic Therapeutics wins gastric ulcer nod for reflux pill Jaqbo - koreabiomed.com","headline":"Onconic Therapeutics wins gastric ulcer nod for reflux pill Jaqbo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPVlo0UlJ3YmZfN1Foa3J1end3NHMyb0hXekVqQ0h3X2l6SVFwcnZlQkdGNXhqZzFGZWMwTUxxZkU5QTBZcUNGNDRheUIxWWVkMkZySm9qMXU0bnVadmVaMGRHdEF6RjU3SDJWM0VqNWQyaUJlUkNWY3puLUNIb1pSbk1HZEtBZFNkdmlkN1EzTmM4bjFkNkFpRHc0NjlZRnpWMDE1VGhkUzg?oc=5","date":"2025-06-17","type":"deal","source":"BioWorld News","summary":"Korea biotech roundup: four financings, six R&D deals mid-June - BioWorld News","headline":"Korea biotech roundup: four financings, six R&D deals mid-June","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE96VjN5TFU4dUxqeUVEcHVLVG9aaGw2TTloSnJ3Y3NhcGY3UjZXS2hjXzdScG41SjJMSHhhc3B2Z3lIaU42dVZVcE5DQUhrY3Z5QnR6NThwS2pjOUdrLWZ3eldaalQ0NDhoNTFHeXVR0gFyQVVfeXFMUFpCclVpdXlqQVVxMk5nWVBpMDZuZE9BdDZhaEd2eEZ2TmhCMk9HTV9sVVh6M2ZzbTNHbVRkR3NVdjhmdU9aRjl4X05EZXltOVhmelZVMlhtb3FsejVndktCWWpZSVBjYzZLajRXSlJiOW5R?oc=5","date":"2025-05-08","type":"deal","source":"koreabiomed.com","summary":"Onconic Therapeutics signs Nordic distribution deal for GERD treatment Jaqbo - koreabiomed.com","headline":"Onconic Therapeutics signs Nordic distribution deal for GERD treatment Jaqbo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1Rc0RxNm4tVGoxY3luY3EzNTVTQlRUbEl1MW42OEdaWWkyM3ZQWVdsTDQ1cHNvQ0xfSmMwcGd2SWh1Vkxua1NCWTN0UEdMS05MeHdXNURJMmVxd3AxQWpWZ2pIajRnQjY5X3hYTURn0gFyQVVfeXFMTXA4bzVxdWwwX0xVUG9zMEZhTXpFWTdtRHM1OWdBTkpqck5Ib2ctc2hTMFdLMTZSNFpyd28yQ3V5ZDQ1OXRONWZmUXpXemRpYk42dFV0NUtHZ1g4TkZJRmltTmE2ZHNOSy1rUFJhR0pjZ09n?oc=5","date":"2025-03-18","type":"regulatory","source":"koreabiomed.com","summary":"Onconic Therapeutics’ nesuparib scores FDA orphan drug designation for gastric cancer - koreabiomed.com","headline":"Onconic Therapeutics’ nesuparib scores FDA orphan drug designation for gastric cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPUHhUSGVxRmYwazgyc3I4SlZkSE9HS0ZxUVExTGRBOGQ1T1l3XzBhaG9Gc19nUVFYTzF0LUxHVlBZR3I2MVBERnJLU2hrN3JpbGhvOGFLYTdLUXhSWjNLalRLemJYa2NDTWNLZlhiOW40dENLNENyMEJIOXA1V2NuU1RVRmNITU9oVERKVUViZmVCaElEX0MwTEtPeWk?oc=5","date":"2024-12-20","type":"pipeline","source":"BioWorld News","summary":"Cancer, GI-focused Onconic shares take off after ₩20B IPO - BioWorld News","headline":"Cancer, GI-focused Onconic shares take off after ₩20B IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBTbmZsYjItWXRQQTUyUWJ5MmRCZlJHVFRpY1N1dVlRRFdFNWJlTmFLQjd2UjI3Wk1SNXNBLTZfUDE3elc1TTVQZkNsLTRqck5MNVFhSTFVc01XU0x0Y2tsTjJ1cFBZamtZOHl6VjBR0gFyQVVfeXFMUFpObkM3MWdsTDJpT2tBWjhtdDlKZl9adjg5OF83QzhpeWNJWk5reUxLQVJkYkxySTZ4VFNoRXNuUXFRSnNYNFNFRnBMZDI1bldpVDM2QjFsaS1xQkxSa014YTFhMnp0YnI5X3N1THBlaU1n?oc=5","date":"2024-10-11","type":"pipeline","source":"koreabiomed.com","summary":"Onconic Therapeutics passes preliminary Kosdaq IPO review - koreabiomed.com","headline":"Onconic Therapeutics passes preliminary Kosdaq IPO review","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE4xS0JXbTBPQUJWbm85d2NyRjRveWhFT2hobk8zN1JjUWxkckNpUmJsZzBHbmltSDZBT3VSM01jTFdlcEdfMmtTZVhzbW9nbmF6VU9QbGdwWTdCR2FHRDkwUzZLOW1fSEdoTTBIZE530gFyQVVfeXFMT1djazFJd0ZaRkluTFJ0czdrR1cxTTY0RTkwSVRZRHVzSHpGaUtRMGFYSVA2QzF1dS1YT3NuZHZuaURMdGxUMmRhajFtLVBjWkVNODltdGRmeHlTMndQc0ZDbDdER1hjOEVEa09BaF9idmdR?oc=5","date":"2024-09-12","type":"pipeline","source":"koreabiomed.com","summary":"Onconic Therapeutics to launch Jaqbo in 19 Latin American countries - koreabiomed.com","headline":"Onconic Therapeutics to launch Jaqbo in 19 Latin American countries","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9sRExNVURUeXdRVVQ4VmhoZi1vRlRWRU1QNGdCd1hKOG9nZU4yU3o5U21wM3ZWcVBTRVhoMjNxbVV1TmxMY1c4czJCV2JnU1B0WjdTdU0tUFNNeVBDNE1rR3BNNjJOMU14QVZUSkh30gFyQVVfeXFMTjE1SkFxcTNDdkxxOWJrRC1OREdja0pNNW5aOHV4bFpzdGJfa1BLYTlZbW9DekFOaEcyNTh3WXItWUNSY3o3VnNzbUt6VHl5WW5BcjRNUWpMNEJjNDd1WGdqTGxDdGl3aU1XdjZYMWdpdHB3?oc=5","date":"2023-03-10","type":"deal","source":"koreabiomed.com","summary":"Onconic Therapeutics licenses out GERD drug candidate to China for $127.5 million - koreabiomed.com","headline":"Onconic Therapeutics licenses out GERD drug candidate to China for $127.5 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE55OU9Ub0lnck1WUGZjUWh4NExYeW8zVU5fVE1jYXZtTE1Mc3RhaGdPQUpWNjFMSGV6YV80S0dBRHVrc0xfUFp0UXFrYlcwM2ExdlJpRlVSeGtTeGNCRUZ5VEpfUVYwU1ltbjAxUmhR?oc=5","date":"2022-12-09","type":"pipeline","source":"KED Global","summary":"New drug developer Onconic Therapeutics raises $20 mn in Series B - KED Global","headline":"New drug developer Onconic Therapeutics raises $20 mn in Series B","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}